← ANALYSTS · TIPRANKS

William Maughan · Clear Street

#1398among 12,504 TipRanks analysts★★★★★★★★★★
Hits 46% 63 of 136 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +16.2% Over a year after the rating, TipRanks’ measure
Our companies rated now 10 Buy / hold / sell: 9 / 1 / 0
Upside of the analyst’s targets +384.8% Average over 10 current targets, to the last price
The market’s answer to the ratings +3.2% Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Aug 18on TipRanks 07:10 OCULIWMOcular Therapeutix · $1.6B Reiterated Buy $28.00 +307.6% +4.1%next day +6.3% · 5 days −1.0%
Aug 7on TipRanks 05:30 KRROIWMKorro Bio · $137M Reiterated Buy $18.00 +112.0% +8.7%next day +1.8% · 5 days −0.2%
Aug 5on TipRanks Aug 4 20:50 DNTHIWMDianthus Therapeutics · $4.2B Reiterated Buy $130 +80.3% +2.1%next day −2.1% · 5 days −0.4%
May 4on TipRanks 12:07 KRYSIWMKrystal Biotech · $9.8B Reiterated Buy $338 → $311−8.0% −1.8% +8.2%next day −1.6% · 5 days +6.1%
Mar 30on TipRanks 19:50 ANNXIWMAnnexon Biosciences · $682M Reiterated Buy $17.00 +398.5% +8.8%next day −4.0% · 5 days +5.3%
Mar 11on TipRanks Mar 10 15:10 BNTXBioNTech SE · $24.1B Reiterated Buy $181 → $167−7.7% +90.4% −17.7%next day +8.4% · 5 days +14.0%
Mar 10on TipRanks 06:35 EDITIWMEditas Medicine · $375M Reiterated Buy $4.60 +95.7% +14.0%next day +0.9% · 5 days −5.9%
Mar 6on TipRanks Mar 5 17:30 CRBUIWMCaribou Biosciences · $50M Reiterated Buy $13.00 +2,671.9% +7.7%next day +7.4% · 5 days +4.8%
Feb 26on TipRanks 20:40 DCTHIWMDelcath Systems · $514M Reiterated Buy $29.00 → $27.00−6.9% +91.8% −0.6%next day +0.3% · 5 days +4.0%
Nov 11on TipRanks Nov 10 15:25 CRSPIWMCrispr Therapeutics AG · $5.0B Reiterated Hold $52.00 → $50.00−3.8% +1.5% −2.5%next day +0.9% · 5 days +3.7%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗